The discovery of antimicrobials as β-lactam antibiotics or aminoglycosides revolutionized the treatment of infectious diseases.
OBJECTIVE: The National Institute of Clinical Excellence (NICE) published guidelines in 2010 recommending the use of cystoscopy to investigate profound lower urinary tract symptoms (pLUTS), recurrent urinary tract infection (rUTI) and pain in men.
BOTHELL, WA USA (Press Release) - July 30, 2012 /PRNewswire via COMTEX/ -- Verathon® Inc. announced today new free, online CAUTI prevention educational materials for healthcare providers at http://verathon.com/products/bladderscan/cauti-zero.
These comprehensive materials include an easy-to-remember CAUTI bundle in poster and animated form, instructional videos with Diane Newman, a renowned expert on urinary issues, an interactive timeline with facts and figures on CAUTI, and additional downloadable educational materials for use by those working to lower and eliminate catheter-associated UTIs in their facilities.
Lowering the high cost of CAUTI.
The Centers for Disease Control and Prevention (CDC) estimates that the direct medical costs of treating healthcare-associated infections (HAIs) in the United States is as high as $45 billion per year.1
Catheter-associated UTIs, the most common HAI, represent 36% of total HAIs. Because CAUTIs have been a prevalent patient safety issue, the Centers for Medicare and Medicaid Services (CMS) in October 2008 issued a new regulation to end reimbursement for the additional costs incurred from preventable CAUTI.2
A national hospital survey, administered by the University of Michigan, examined prevention practices in use between 2005 and 2009. While CAUTI prevention practices remain inadequate, the only practice used by 50% or more of the hospitals was portable bladder volume ultrasound.3
Helping nurses meet the CAUTI challenge.
As the manufacturer of BladderScan® portable bladder volume ultrasound instruments, Verathon is proud to play a key role in supporting CAUTI prevention education that can help nurses and infection prevention staff eliminate unnecessary urinary (Foley) catheterization and reduce costs.
"The Joint Commission has made CAUTIs a 2012 National Patient Safety Goal," states CAUTI expert Diane K. Newman, DNP FAAN BCB-PMD. "Increasing awareness of best practices for minimizing catheterization and ensuring early Foley catheter removal clearly helps promote safe patient care, while reducing costs from unnecessary catheter-associated UTIs."
To help nurses meet this National Patient Safety Goal, Verathon is providing the following free educational tools online to help raise awareness about CAUTI prevention practices:
White Paper: This updated version of "Removing Indwelling Catheters in Acute Care: A Step-By-Step Clinical Pathway for Nurses" by Diane K. Newman provides the most current evidence-based clinical information on managing Foley catheters. Available at UroToday and http://verathon.com/products/bladderscan/cauti-zero.
CAUTI Bundle Poster: Designed for staff lounges and nursing stations, this eye-catching poster displays a CAUTI bundle checklist in five memorable steps. Downloadable PDF available at UroToday and http://verathon.com/products/bladderscan/cauti-zero .
CAUTI Bundle Checklist (animated): This animated version of the checklist is perfect for presentations to staff on CAUTI elimination best practices. Available at http://verathon.com/products/bladderscan/cauti-zero .
CAUTI Interactive Timeline: This compelling "CAUTI Chronology" offers a decade of fast facts in the fight against CAUTI. Downloadable PDF available at UroToday and http://verathon.com/products/bladderscan/cauti-zero .
Demonstration Videos: Learn how to measure bladder volume with the BladderScan portable ultrasound device in these three patient demonstration videos presented by Diane K. Newman. Now showing on YouTube, UroToday and http://verathon.com/products/bladderscan/cauti-zero .
Acute Care Manual: "Managing Urinary Retention in the Acute Care Setting" is a comprehensive guide to safe patient care through the application of noninvasive bladder management. Available at http://verathon.com/products/bladderscan/cauti-zero .
On the front line of CAUTI prevention.
Verathon and UroToday, the leading global urological disease-focused online resource, launched the CAUTI Center in December 2009 to provide access to the latest commentary from CAUTI expert Diane Newman, as well as recent publications and experiences from those in the CAUTI treatment community. Today, that center, now known as The CAUTI Challenge, has become a definitive source of CAUTI prevention information for practitioners.
"UroToday is extremely proud of The CAUTI Challenge effort," says Gina Carithers, CEO of UroToday and Publisher of UroToday International Journal. "UroToday, Diane Newman and the team at BladderScan, are steadfastly committed to providing the best educational tools to assist healthcare professionals in reducing, and ultimately eliminating, dangerous and costly catheter-associated urinary tract infections."
About Verathon Inc.
Verathon designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the healthcare community. The company's noninvasive BladderScan® instrument is a standard of care for portable bladder volume measurement. The brand is found in over 60 countries in Acute Care, Urology and Primary Care practices, as well as Extended Care facilities. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon entered Anesthesiology, Critical Care and Emergency markets with the GlideScope® video laryngoscope brand. Verathon is headquartered in Bothell, Washington and operates as a subsidiary of Roper Industries. For more information, please visit verathon.com.
About Roper Industries
Roper Industries is a market-driven, diversified growth company and is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Roper provides engineered products and solutions for global niche markets, including water, energy, transportation, medical, education, and SaaS-based information networks. Additional information about Roper Industries is available on the Company's website at roperind.com.
Verathon Media Contacts:
Lorraine Silva, Director - Marketing Operations, Verathon Medical, 425.867.1348 (Ext. 5604).
Alternate Contact: Jane Mueller, VP of Marketing, 425.867.1348 (Ext. 5600).
References:
All of the resources detailed in this release are also available at www.cautichallenge.com.
[ PRESS RELEASE ]
Uncomplicated urinary tract infections are commonly encountered in primary care and frequently lead to empirical antibiotic prescriptions.
Escherichia coli-associated urinary tract infections (UTIs) are among the most common bacterial infections in humans.
PURPOSE: To exclude urinary tract infections, culture is the gold standard method, although it is time consuming and costly.
BACKGROUND/PURPOSE: Proteus mirabilis is a common pathogen responsible for complicated urinary tract infections (UTIs) that sometimes causes bacteremia.
BERKELEY, CA (UroToday.com) - The indwelling urinary catheter is the most common cause of infections in hospitals and other healthcare facilities.[1] As long ago as 1958, Paul Beeson [2] warned ‘...the decision to use this instrument should be made with the knowledge that it involves the risk of producing a serious disease which is often difficult to treat.' 
Since then, scientific studies have progressed revealing a greater understanding of the bladder’s defence mechanisms against infection and how they are undermined by the Foley catheter.[3-5] In addition, the complications caused by the development of bacterial biofilms on catheters have been recognised and the ways in which these bacterial communities develop on catheters have become clear.[5, 6] It is now obvious that fundamental problems with the basic design of the catheter, which has changed little since it was introduced into urological practice by Dr. Fredricc Foley in 1937,[7] induce susceptibility to infection. These issues need to be addressed urgently if we are to produce a device suitable for use in the 21st century...View or save the full text Mini Review as a .pdf file
| What's known on the subject? and What does the study add? A vast literature has been published on the prevalence, morbidity and microbiology of catheter-associated urinary tract infections. Research and development in recent years has focused on producing antibacterial coatings for the indwelling Foley catheter with insufficient attention to its design. This article provides a critical examination of the design of the indwelling Foley catheter. Design specifications are outlined for a urine collection device that should reduce the vulnerability of catheterised urinary tract to infection. |
Roger C.L. Feneley, Calvin M. Kunin,* and David J. Stickler†
North Bristol NHS Trust, Southmead Hospital, Bristol, England, †School of Biosciences, Cardiff University, Cardiff, Wales, UK, *Department of Medicine, University of Arizona, Tuscon, Arizona,and Dept of Medicine, Ohio State University, Columbus Ohio, USA
More BJUI Mini Reviews and Archives
BACKGROUND:Patients with diabetes mellitus have an increased risk of infection.
Worldwide, Escherichia coli is a leading cause of bloodstream infections.
The efficacy and safety of ertapenem, 1 g once daily, were compared with that of ceftriaxone, 2 g once daily, for the treatment of adults with acute pyelonephritis (APN) and complicated urinary tract infections (cUTIs) in a prospective, multicenter, double-blinded, randomized study.
Empirical diagnosis and treatment of lower urinary tract infection (UTI) in women is the most common clinical approach due to the urgency of symptoms and cost.
Most infections of the upper urinary tract are straightforward and do not require any emergency radiological investigations.
In epididymo-orchitis, a sonogram shows a non-homogenous and hypertrophied epididymis and testis, with increased vascularisation seen on a Doppler sonogram.
KYOTO, JAPAN (UroToday.com) -
Who needs a urine culture prior to SWL? Answer: Everyone
